{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:59:27Z","timestamp":1777395567889,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T00:00:00Z","timestamp":1678492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T00:00:00Z","timestamp":1678492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN) are serious and rare diseases, most often drug-induced, and their incidence has been estimated at 6 cases\/million\/year in France. SJS and TEN belong to the same spectrum of disease known as epidermal necrolysis (EN). They are characterized by more or less extensive epidermal detachment, associated with mucous membrane involvement, and may be complicated during the acute phase by fatal multiorgan failure. SJS and TEN can lead to severe ophthalmologic sequelae. There are no recommendations for ocular management during the chronic phase. We conducted a national audit of current practice in the 11 sites of the French reference center for toxic bullous dermatoses and a review of the literature to establish therapeutic consensus guidelines. Ophthalmologists and dermatologists from the French reference center for epidermal necrolysis were asked to complete a questionnaire on management practices in the chronic phase of SJS\/TEN. The survey focused on the presence of a referent ophthalmologist at the center, the use of local treatments (artificial tears, corticosteroid eye drops, antibiotic-corticosteroids, antiseptics, vitamin A ointment (VA), cyclosporine, tacrolimus), the management of trichiatic eyelashes, meibomian dysfunction, symblepharons, and corneal neovascularization, as well as the contactologic solutions implemented. Eleven ophthalmologists and 9 dermatologists from 9 of the 11 centers responded to the questionnaire. Based on questionnaire results, 10\/11 ophthalmologists systematically prescribed preservative-free artificial tears, and 11\/11 administered VA. Antiseptic or antibiotic eye drops or antibiotic-corticosteroid eye drops were recommended as needed by 8\/11 and 7\/11 ophthalmologists, respectively. In case of chronic inflammation, topical cyclosporine was consistently proposed by 11\/11 ophthalmologists. The removal of trichiatic eyelashes was mainly performed by 10\/11 ophthalmologists. Patients were referred to a reference center for fitting of scleral lenses (10\/10,100%). Based on this practice audit and literature review, we propose an evaluation form to facilitate ophthalmic data collection in the chronic phase of EN and we also propose an algorithm for the ophthalmologic management of ocular sequelae.<\/jats:p>","DOI":"10.1186\/s13023-023-02616-6","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:23:13Z","timestamp":1679862193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Ocular sequelae of epidermal necrolysis: French national audit of practices, literature review and proposed management"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8997-8376","authenticated-orcid":false,"given":"Dhyna","family":"Thorel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"Ingen-Housz-Oro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Bena\u00efm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Daien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Gabison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentine","family":"Saunier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"B\u00e9ral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Touboul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Br\u00e9mond-Gignac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthieu","family":"Robert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Vasseur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rard","family":"Royer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Dereure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Milpied","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Bernier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Welfringer-Morin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Bodemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nad\u00e8ge","family":"Cordel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Tauber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carole","family":"Burillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Servant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chloe","family":"Couret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Vabres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"T\u00e9tart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myriam","family":"Cassagne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Ange","family":"Kuoch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Muraine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agn\u00e8s","family":"Delcampe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Gueudry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,11]]},"reference":[{"key":"2616_CR1","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/bjd.18424","volume":"182","author":"G Chaby","year":"2020","unstructured":"Chaby G, Maldini C, Haddad C, Lebrun-Vignes B, Hemery F, Ingen-Housz-Oro S, et al. Incidence of and mortality from epidermal necrolysis (Stevens-Johnson syndrome\/toxic epidermal necrolysis) in France during 2003\u201316: a four-source capture-recapture estimate. Br J Dermatol. 2020;182:618\u201324.","journal-title":"Br J Dermatol"},{"key":"2616_CR2","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1016\/S0140-6736(16)30378-6","volume":"390","author":"TA Duong","year":"2017","unstructured":"Duong TA, Valeyrie-Allanore L, Wolkenstein P, Chosidow O. Severe cutaneous adverse reactions to drugs. Lancet Lond Engl. 2017;390:1996\u20132011.","journal-title":"Lancet Lond Engl"},{"key":"2616_CR3","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/ICU.0000000000000312","volume":"27","author":"HN Saeed","year":"2016","unstructured":"Saeed HN, Chodosh J. Ocular manifestations of Stevens-Johnson syndrome and their management. Curr Opin Ophthalmol. 2016;27:522\u20139.","journal-title":"Curr Opin Ophthalmol"},{"key":"2616_CR4","first-page":"157","volume":"145","author":"J Gueudry","year":"2009","unstructured":"Gueudry J, Roujeau J-C, Binaghi M, Soubrane G, Muraine M. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol. 2009;145:157\u201362.","journal-title":"Arch Dermatol"},{"key":"2616_CR5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/bjd.17627","volume":"181","author":"D Thorel","year":"2019","unstructured":"Thorel D, Delcampe A, Ingen-Housz-Oro S, Hajj C, Gabison E, Chosidow O, et al. Dark skin phototype is associated with more severe ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol. 2019;181:212\u20133.","journal-title":"Br J Dermatol"},{"key":"2616_CR6","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1136\/bjo.2006.109124","volume":"91","author":"MV De Rojas","year":"2007","unstructured":"De Rojas MV, Dart JKG, Saw VPJ. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy. Br J Ophthalmol. 2007;91:1048\u201353.","journal-title":"Br J Ophthalmol"},{"key":"2616_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13023-020-01538-x","volume":"15","author":"D Thorel","year":"2020","unstructured":"Thorel D, Ingen-Housz-Oro S, Royer G, Delcampe A, Bellon N, Bodemer C, et al. Management of ocular involvement in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: french national audit of practices, literature review, and consensus agreement. Orphanet J Rare Dis. 2020;15:259.","journal-title":"Orphanet J Rare Dis"},{"key":"2616_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.657327","volume":"8","author":"C Sotozono","year":"2021","unstructured":"Sotozono C, Ueta M, Kinoshita S. Japan: diagnosis and management of Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis with severe ocular complications. Front Med. 2021;8: 657327.","journal-title":"Front Med"},{"key":"2616_CR9","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.ajo.2009.07.006","volume":"148","author":"B Tougeron-Brousseau","year":"2009","unstructured":"Tougeron-Brousseau B, Delcampe A, Gueudry J, Vera L, Doan S, Hoang-Xuan T, et al. Vision-related function after scleral lens fitting in ocular complications of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Am J Ophthalmol. 2009;148:852-859.e2.","journal-title":"Am J Ophthalmol"},{"key":"2616_CR10","doi-asserted-by":"crossref","unstructured":"Sotozono C, Ueta M, Yokoi N. Severe Dry Eye With Combined Mechanisms is Involved in the Ocular Sequelae of SJS\/TEN at the Chronic Stage. Invest Ophthalmol Vis Sci. 2018;59:DES80\u20136.","DOI":"10.1167\/iovs.18-24019"},{"key":"2616_CR11","unstructured":"Roujeau JC, Phlippoteau C, Koso M, Wechsler J, Binaghi M, Revuz J, et al. [Ocular sequelae and sicca syndrome following Lyell\u2019s syndrome]. Ann Dermatol Venereol. 1985;112:883\u20138."},{"key":"2616_CR12","doi-asserted-by":"crossref","unstructured":"Di Pascuale MA, Espana EM, Liu DT-S, Kawakita T, Li W, Gao YY, et al. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome. Ophthalmology. 2005;112:904\u201312.","DOI":"10.1016\/j.ophtha.2004.11.035"},{"key":"2616_CR13","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.jcrs.2007.04.041","volume":"33","author":"H Isawi","year":"2007","unstructured":"Isawi H, Dhaliwal DK. Corneal melting and perforation in Stevens Johnson syndrome following topical bromfenac use. J Cataract Refract Surg. 2007;33:1644\u20136.","journal-title":"J Cataract Refract Surg"},{"key":"2616_CR14","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3109\/02713683.2011.587935","volume":"36","author":"N Phasukkijwatana","year":"2011","unstructured":"Phasukkijwatana N, Lertrit P, Liammongkolkul S, Prabhasawat P. Stability of epitheliotrophic factors in autologous serum eye drops from chronic Stevens-Johnson syndrome dry eye compared to non-autoimmune dry eye. Curr Eye Res. 2011;36:775\u201381.","journal-title":"Curr Eye Res"},{"key":"2616_CR15","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S1542-0124(12)70014-9","volume":"1","author":"V Wall","year":"2003","unstructured":"Wall V, Yen MT, Yang M-C, Huang AJW, Pflugfelder SC. Management of the Late Ocular Sequelae of Stevens-Johnson Syndrome. Ocul Surf. 2003;1:192\u2013201.","journal-title":"Ocul Surf"},{"key":"2616_CR16","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/S0161-6420(88)33009-5","volume":"95","author":"HK Soong","year":"1988","unstructured":"Soong HK, Martin NF, Wagoner MD, Alfonso E, Mandelbaum SH, Laibson PR, et al. Topical retinoid therapy for squamous metaplasia of various ocular surface disorders. Ophthalmology. 1988;95:1442\u20136.","journal-title":"Ophthalmology"},{"key":"2616_CR17","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jtos.2016.02.001","volume":"14","author":"S Kohanim","year":"2016","unstructured":"Kohanim S, Palioura S, Saeed HN, Akpek EK, Amescua G, Basu S, et al. Acute and chronic ophthalmic involvement in stevens-johnson syndrome\/toxic epidermal necrolysis\u2014a comprehensive review and guide to therapy II. Ophthalmic Disease. Ocul Surf. 2016;14:168\u201388.","journal-title":"Ocul Surf"},{"key":"2616_CR18","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1089\/jop.2012.0009","volume":"29","author":"P Prabhasawat","year":"2013","unstructured":"Prabhasawat P, Tesavibul N, Karnchanachetanee C, Kasemson S. Efficacy of cyclosporine 0.05% eye drops in Stevens Johnson syndrome with chronic dry eye. J Ocul Pharmacol Ther Off J Assoc Ocul Pharmacol Ther. 2013;29:372\u20137.","journal-title":"J Ocul Pharmacol Ther Off J Assoc Ocul Pharmacol Ther"},{"key":"2616_CR19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jtos.2014.12.006","volume":"13","author":"KH Wan","year":"2015","unstructured":"Wan KH, Chen LJ, Young AL. Efficacy and safety of topical 0.05% cyclosporine eye drops in the treatment of dry eye syndrome: a systematic review and meta-analysis. Ocul Surf. 2015;13:213\u201325.","journal-title":"Ocul Surf"},{"key":"2616_CR20","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1016\/j.ophtha.2005.05.013","volume":"112","author":"LD Barber","year":"2005","unstructured":"Barber LD, Pflugfelder SC, Tauber J, Foulks GN. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years. Ophthalmology. 2005;112:1790\u20134.","journal-title":"Ophthalmology"},{"key":"2616_CR21","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1038\/s41598-020-60794-w","volume":"10","author":"T Kittipibul","year":"2020","unstructured":"Kittipibul T, Puangsricharern V, Chatsuwan T. Comparison of the ocular microbiome between chronic Stevens-Johnson syndrome patients and healthy subjects. Sci Rep. 2020;10:4353.","journal-title":"Sci Rep"},{"key":"2616_CR22","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1136\/bjo.85.10.1188","volume":"85","author":"AC Poon","year":"2001","unstructured":"Poon AC, Geerling G, Dart JK, Fraenkel GE, Daniels JT. Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol. 2001;85:1188\u201397.","journal-title":"Br J Ophthalmol"},{"key":"2616_CR23","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1097\/ICO.0b013e3182910036","volume":"32","author":"O Thanathanee","year":"2013","unstructured":"Thanathanee O, Phanphruk W, Anutarapongpan O, Romphruk A, Suwan-Apichon O. Contamination risk of 100% autologous serum eye drops in management of ocular surface diseases. Cornea. 2013;32:1116\u20139.","journal-title":"Cornea"},{"key":"2616_CR24","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.ajo.2012.12.009","volume":"155","author":"YJ Lee","year":"2013","unstructured":"Lee YJ, Kim SW, Seo KY. Application for tacrolimus ointment in treating refractory inflammatory ocular surface diseases. Am J Ophthalmol. 2013;155:804\u201313.","journal-title":"Am J Ophthalmol"},{"key":"2616_CR25","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1097\/SCS.0000000000004584","volume":"29","author":"TH Osaki","year":"2018","unstructured":"Osaki TH, Sant\u2019Anna AE, Osaki MH, Kikkawa DO, Yabumoto C, Yang P, et al. Management of severe cicatricial entropion with labial mucous membrane graft in cicatricial ocular surface disorders. J Craniofac Surg. 2018;29:1531\u20134.","journal-title":"J Craniofac Surg"},{"key":"2616_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ajo.2020.08.022","volume":"222","author":"R Venugopal","year":"2021","unstructured":"Venugopal R, Nagpal R, Mohanty S, Sen S, Kashyap S, Agarwal T, et al. Outcomes of cultivated oral mucosal epithelial transplantation in eyes with chronic Stevens-Johnson syndrome sequelae. Am J Ophthalmol. 2021;222:82\u201391.","journal-title":"Am J Ophthalmol"},{"key":"2616_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/ICO.0b013e318247983d","volume":"32","author":"A Kheirkhah","year":"2013","unstructured":"Kheirkhah A, Ghaffari R, Kaghazkanani R, Hashemi H, Behrouz MJ, Raju VK. A combined approach of amniotic membrane and oral mucosa transplantation for fornix reconstruction in severe symblepharon. Cornea. 2013;32:155\u201360.","journal-title":"Cornea"},{"key":"2616_CR28","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.ajo.2011.03.011","volume":"152","author":"Y Fu","year":"2011","unstructured":"Fu Y, Liu J, Tseng SCG. Oral mucosal graft to correct lid margin pathologic features in cicatricial ocular surface diseases. Am J Ophthalmol. 2011;152:600-608.e1.","journal-title":"Am J Ophthalmol"},{"key":"2616_CR29","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/S0161-6420(87)80013-1","volume":"94","author":"GB Bartley","year":"1987","unstructured":"Bartley GB, Bullock JD, Olsen TG, Lutz PD. An experimental study to compare methods of eyelash ablation. Ophthalmology. 1987;94:1286\u20139.","journal-title":"Ophthalmology"},{"key":"2616_CR30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5301\/ejo.5000391","volume":"24","author":"VS Liarakos","year":"2014","unstructured":"Liarakos VS, Papaconstantinou D, Vergados I, Douvali M, Theodossiadis PG. The effect of subconjunctival ranibizumab on corneal and anterior segment neovascularization: study on an animal model. Eur J Ophthalmol. 2014;24:299\u2013308.","journal-title":"Eur J Ophthalmol"},{"key":"2616_CR31","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jfo.2010.07.007","volume":"33","author":"J Gueudry","year":"2010","unstructured":"Gueudry J, Richez F, Tougeron-Brousseau B, Genevois O. Muraine M [Subconjunctival bevacizumab for corneal neovascularization]. J Fr Ophtalmol. 2010;33:630\u20136.","journal-title":"J Fr Ophtalmol"},{"key":"2616_CR32","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.ajo.2014.07.012","volume":"158","author":"C Sotozono","year":"2014","unstructured":"Sotozono C, Yamauchi N, Maeda S, Kinoshita S. Tear exchangeable limbal rigid contact lens for ocular sequelae resulting from Stevens-Johnson syndrome or toxic epidermal necrolysis. Am J Ophthalmol. 2014;158:983\u201393.","journal-title":"Am J Ophthalmol"},{"key":"2616_CR33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1056\/NEJM200007133430202","volume":"343","author":"RJ-F Tsai","year":"2000","unstructured":"Tsai RJ-F, Li L-M, Chen J-K. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N Engl J Med. 2000;343:86\u201393.","journal-title":"N Engl J Med"},{"key":"2616_CR34","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jfo.2016.08.001","volume":"39","author":"V Kocaba","year":"2016","unstructured":"Kocaba V, Damour O, Auxenfans C, Burillon C. Traitement du d\u00e9ficit en cellules souches limbiques. Revue de la litt\u00e9rature. J Fr Ophtalmol. 2016;39:791\u2013803.","journal-title":"J Fr Ophtalmol"},{"key":"2616_CR35","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1136\/bjophthalmol-2020-316056","volume":"105","author":"Y Yang","year":"2021","unstructured":"Yang Y, Fung SSM, Chew H, Mireskandari K, Ali A. Amniotic membrane transplantation for Stevens-Johnson syndrome\/toxic epidermal necrolysis: the Toronto experience. Br J Ophthalmol. 2021;105:1238\u201343.","journal-title":"Br J Ophthalmol"},{"key":"2616_CR36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1471-2415-14-97","volume":"14","author":"F Wang","year":"2014","unstructured":"Wang F, Li S, Wang T, Gao H, Shi W. Modified tectonic keratoplasty with minimal corneal graft for corneal perforation in severe Stevens-Johnson syndrome: a case series study. BMC Ophthalmol. 2014;14:97.","journal-title":"BMC Ophthalmol"},{"key":"2616_CR37","doi-asserted-by":"publisher","unstructured":"Urban M, Muraine M. L\u2019ost\u00e9o-odonto-k\u00e9ratoproth\u00e8se\u202f: la dent et son parodonte au secours du globe oculaire. 65\u00e8me Congr\u00e8s SFCO [Internet]. Rouen, France: EDP Sciences; 2017 [cited 2022 Jan 25]. p. 02023. https:\/\/doi.org\/10.1051\/sfco\/20176502023","DOI":"10.1051\/sfco\/20176502023"},{"key":"2616_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jtos.2012.01.003","volume":"10","author":"A Tan","year":"2012","unstructured":"Tan A, Tan DT, Tan X-W, Mehta JS. Osteo-odonto keratoprosthesis: systematic review of surgical outcomes and complication rates. Ocul Surf. 2012;10:15\u201325.","journal-title":"Ocul Surf"},{"key":"2616_CR39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0002-9394(14)71962-2","volume":"122","author":"K Tsubota","year":"1996","unstructured":"Tsubota K, Satake Y, Ohyama M, Toda I, Takano Y, Ono M, et al. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol. 1996;122:38\u201352.","journal-title":"Am J Ophthalmol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02616-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02616-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02616-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:24:02Z","timestamp":1679862242000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02616-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,11]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2616"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02616-6","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,11]]},"assertion":[{"value":"5 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}